What is
AstutePlus®?
AstutePlus® advanced antithrombogenic is the only zero-leaching, permanently effective Surface-Active Therapeutic designed for long-term blood-contacting medical devices. The active agents of AstutePlus® work with passive elements to block the blood cascade, deactivate platelets and hinder blood components and proteins from sticking to the device surface.
Clinical Features
Prevents 99% of Thrombosis
Prevents Fibrin Sheath
Mimics Endothelial Tissue
Permanently Effective
Zero Leaching
No Particulates
This reduces thrombus formation and prevents fibrin sheath development, ensuring the implant remains shielded and protected for decades, with no patient side-effects. This multi-faceted antithrombogenic solution improves biocompatibility, elevates antithrombogenic performance and supports the therapeutic effects of anticoagulation. This combination increases safety, optimises device performance and supports a better quality of life for the patient.
Biocompatibility Evaluation
AstutePlus®is an Advanced Antithrombogenic Surface Active Therapeutic derived from our proven technology platform, used for over 30 years on FDA-approved and CE-approved medical devices without rejection or recall. It has been successfully tested to ISO biocompatibility standards, including:
Clinical Areas
Neurovascular
Renal Care
Cardiovascular Products
Vascular Access
Cardiopulmonary
Cardiac Rhythm
Various Substrates We Coat
